FibroGen China
Newsroom
Contact
Fibrogen_US_logo_rgb.png

  • About Us

    • Our Company
    • Our Strategy
    • FibroGen China
    • Executive Team
    • Board of Directors
    • Our Partners
    • Contact Us

  • Focus Area

    • Our Expertise
    • Anemia
    • Pancreatic Cancer
    • Duchenne Muscular Dystrophy
    • Idiopathic Pulmonary Fibrosis
    • Publications

  • Pipeline

    • R&D Pipeline
    • Roxadustat
    • Pamrevlumab

  • Clinical Trials

    • Our Priorities
    • Roxadustat Trials
    • Pamrevlumab Trials

  • Careers

    • Our Culture
    • Career Opportunities

  • Investors and Media

    • Investor Overview
    • Stock Information
    • News Releases
    • Events and Presentations
    • Corporate Governance
    • SEC Filings
    • Financial Information
    • Shareholder Services
    • Investor FAQs

  • More

    Use tab to navigate through the menu items.
    About-Us_Hero0.jpg

    Contact Us

    FibroGen, Inc. Headquarters

    409 Illinois Street
    San Francisco, CA 94158 USA


    Phone: +1 415.978.1200
    Fax: +1 415.978.1902

    About Us
    Our Company
    Our Strategy
    FibroGen China
    Executive Team
    Board of Directors
    Our Partners
    Contact Us
    Focus Areas
    Our Expertise
    Anemia
    Idiopathic Pulmonary Fibrosis
    Pipeline
    R&D Pipeline
    Roxadustat
    Pamrevlumab
    Pancreatic Cancer
    Duchenne Muscular Dystrophy
    Publications
    Clinical Trials
    Our Priorities
    Roxadustat Trials
    Careers
    Our Culture
    Career Opportunities
    Pamrevlumab Trials
    Investors & Media
    Investor Overview
    Stock Information
    Press Releases
    Events and Presentations
    Corporate Governance
    SEC Filings
    Financial information
    Shareholder Services
    Investor FAQs
    Fibrogen_US_logo_rgb.png

    © 2022 FibroGen, Inc.    409 Illinois Street, San Francisco, CA 94158

    • LinkedIn
    • Twitter
    Terms of Use
    Privacy Notice